Biotech Exscientia has signed an agreement with Sanofi to develop up to 15 new drug candidates in oncology and immunology using Exscientia’s artificial intelligence platform. As part of the deal,…
Read More
The French pharmaceutical CEO was called to the Elysee Palace for a meeting with Emmanuel Macron. At the end of the meeting, the presidency issued a statement saying that Sanofi…
Read MorePage 1 of 1